CDMO Best Practices from Benches to Batches - How to Transition from Clinical to Commercial Readiness
Product
Information
What you need to seamlessly transition from clinical phases to commercial readiness. Three unique abilities your CDMO must have to complete your project within your timeline are capability, flexibility and availability. August Bioservices' Director of Customer Operations, Commercial Development, offers several insights as to why August Bioservices is rapidly moving from the best kept secret in the CDMO industry, to one of the fastest-growing and most sought-after partners in the sterile injectables space.
Distribution Areas
North America (USA, Canada)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)
Supplied From
United States
Main Categories
Finished Dosage Forms (Products)Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)
All Categories
InjectablesContract ManufacturingContract Manufacturing of Dosage Form Drugs
